Clinical TrialsAscletis’ GLP-1 ASC30 Depot Injection Achieves Promising Phase 2 Results ... Ascletis’ GLP-1 ASC30 Depot Injection Achieves Promising Phase 2 Results ... Read Post »
Drugs Safety AlertFDA Issues Warning Letter to Novo Nordisk Over Pharmacovigilance Deficienci... FDA Issues Warning Letter to Novo Nordisk Over Pharmacovigilance Deficienci... Read Post »
Clinical TrialsTelix Reports Positive Safety Results from Phase 3 ProstACT Global Trial of... Telix Reports Positive Safety Results from Phase 3 ProstACT Global Trial of... Read Post »
Clinical TrialsVertex’s Povetacicept Cuts Proteinuria by 52% in Phase 3 RAINIER Interim ... Vertex’s Povetacicept Cuts Proteinuria by 52% in Phase 3 RAINIER Interim ... Read Post »
New Drug ApprovalFDA Approves Wellcovorin (Leucovorin Calcium) as First Treatment for Rare F... FDA Approves Wellcovorin (Leucovorin Calcium) as First Treatment for Rare F... Read Post »
Drugs Safety AlertIpsen Withdraws Tazverik After SYMPHONY-1 Trial Flags Secondary Blood Cance... Ipsen Withdraws Tazverik After SYMPHONY-1 Trial Flags Secondary Blood Cance... Read Post »
Clinical TrialsAbbVie Reports Up to 9.8% Weight Loss in Phase 1 MAD Trial of Long-Acting A... AbbVie Reports Up to 9.8% Weight Loss in Phase 1 MAD Trial of Long-Acting A... Read Post »
Clinical TrialsRegeneron, Hansoh Report 19.3% Weight Loss with Dual GLP-1/GIP Drug Olatore... Regeneron, Hansoh Report 19.3% Weight Loss with Dual GLP-1/GIP Drug Olatore... Read Post »
Clinical TrialsPfizer’s Trispecific Antibody Tilrekimig Shows Positive Phase 2 Results i... Pfizer’s Trispecific Antibody Tilrekimig Shows Positive Phase 2 Results i... Read Post »
Clinical TrialsRoche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer Roche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer Read Post »
Clinical TrialsImmunityBio Files Updated ANKTIVA sBLA with FDA for Papillary NMIBC ImmunityBio Files Updated ANKTIVA sBLA with FDA for Papillary NMIBC Read Post »
New Drug ApprovalFDA Approves PYLARIFY TruVu for PSMA PET Imaging in Prostate Cancer FDA Approves PYLARIFY TruVu for PSMA PET Imaging in Prostate Cancer Read Post »
New Drug ApprovalEuropean Commission Approves Incyte’s Zynyz Combination Therapy for First... European Commission Approves Incyte’s Zynyz Combination Therapy for First... Read Post »
Clinical TrialsJOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study JOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study Read Post »
Clinical TrialsHelus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Helus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Read Post »
New Drug ApprovalFDA Approves Bristol Myers Squibb’s Sotyktu as First TYK2 Inhibitor for A... FDA Approves Bristol Myers Squibb’s Sotyktu as First TYK2 Inhibitor for A... Read Post »
Clinical TrialsRoche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Roche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Read Post »
Clinical TrialsRoche’s Amylin Analog Petrelintide Delivers Up to 10.7% Weight Loss in Ph... Roche’s Amylin Analog Petrelintide Delivers Up to 10.7% Weight Loss in Ph... Read Post »
Clinical TrialsFDA Places Partial Clinical Hold on PepGen’s FREEDOM2-DM1 Trial of PGN-ED... FDA Places Partial Clinical Hold on PepGen’s FREEDOM2-DM1 Trial of PGN-ED... Read Post »
ResearchGLP-1 Weight Loss Is Driving New Demand for Facial Aesthetic Treatments, Al... GLP-1 Weight Loss Is Driving New Demand for Facial Aesthetic Treatments, Al... Read Post »
Clinical TrialsFibroBiologics Nears Trial Initiation for CYWC628 in Diabetic Foot Ulcers FibroBiologics Nears Trial Initiation for CYWC628 in Diabetic Foot Ulcers Read Post »
New Drug ApprovalJ&J’s TECVAYLI–DARZALEX FASPRO Combo Wins FDA Approval After MajesT... J&J’s TECVAYLI–DARZALEX FASPRO Combo Wins FDA Approval After MajesT... Read Post »
Clinical TrialsBiogen and Stoke Therapeutics Report Up to 91% Seizure Reduction with Zorev... Biogen and Stoke Therapeutics Report Up to 91% Seizure Reduction with Zorev... Read Post »
New Drug ApprovalGlenmark Secures FDA Approval and CGT Exclusivity for Generic Fluticasone Glenmark Secures FDA Approval and CGT Exclusivity for Generic Fluticasone Read Post »
Clinical TrialsAmpreloxetine Misses Primary Endpoint in MSA-nOH CYPRESS Trial, Triggers Sa... Ampreloxetine Misses Primary Endpoint in MSA-nOH CYPRESS Trial, Triggers Sa... Read Post »
New Drug ApprovalAgios’ PYRUKYND Gains UAE Approval as First Therapy for Thalassemia P... Agios’ PYRUKYND Gains UAE Approval as First Therapy for Thalassemia P... Read Post »
Drugs Safety AlertKyowa Kirin Discontinues All Rocatinlimab Trials Over Emerging Malignancy R... Kyowa Kirin Discontinues All Rocatinlimab Trials Over Emerging Malignancy R... Read Post »
Clinical TrialsIntellia Unveils Striking Long-Term Data on CRISPR Therapy Lonvo-z for Here... Intellia Unveils Striking Long-Term Data on CRISPR Therapy Lonvo-z for Here... Read Post »
Clinical TrialsMerck, Eisai Advance Dual Oral Therapy with Strong Phase 3 RCC Data at ASCO... Merck, Eisai Advance Dual Oral Therapy with Strong Phase 3 RCC Data at ASCO... Read Post »
Clinical Trials55% Risk Reduction: Ralinepag’s ADVANCE OUTCOMES Results Signal New P... 55% Risk Reduction: Ralinepag’s ADVANCE OUTCOMES Results Signal New P... Read Post »
New Drug ApprovalHERNEXEOS® Gains FDA Nod as First-Line Option for HER2-Mutant NSCLC HERNEXEOS® Gains FDA Nod as First-Line Option for HER2-Mutant NSCLC Read Post »
New Drug ApprovalFDA Approves Once-Weekly YUVIWEL® for Pediatric Achondroplasia FDA Approves Once-Weekly YUVIWEL® for Pediatric Achondroplasia Read Post »
Clinical TrialsAbbVie’s SKYRIZI Shows Strong Induction Results in Hard-to-Treat Crohn’... AbbVie’s SKYRIZI Shows Strong Induction Results in Hard-to-Treat Crohn’... Read Post »
Clinical TrialsMerck Reports Positive Phase 3 Results Across Ovarian, Bladder, and Renal C... Merck Reports Positive Phase 3 Results Across Ovarian, Bladder, and Renal C... Read Post »
Clinical TrialsSystImmune and BMS Report Dual PFS/OS Wins for Iza-Bren in Advanced TNBC Ph... SystImmune and BMS Report Dual PFS/OS Wins for Iza-Bren in Advanced TNBC Ph... Read Post »
Clinical TrialsOrganon Highlights VTAMA Family Sleep Benefits in ADORING Trials Organon Highlights VTAMA Family Sleep Benefits in ADORING Trials Read Post »
Clinical TrialsLilly’s Olumiant Shows Strong Hair Regrowth in Adolescents with Sever... Lilly’s Olumiant Shows Strong Hair Regrowth in Adolescents with Sever... Read Post »
New Drug ApprovalFDA Approves BioMarin PALYNZIQ for Adolescents with PKU FDA Approves BioMarin PALYNZIQ for Adolescents with PKU Read Post »
Clinical TrialsBayer’s PEACE‑3 Phase III Trial Shows Enzalutamide Plus Radium‑223 Im... Bayer’s PEACE‑3 Phase III Trial Shows Enzalutamide Plus Radium‑223 Im... Read Post »
Clinical TrialsGalderma’s Nemluvio Shows Sustained Efficacy and Safety in Prurigo No... Galderma’s Nemluvio Shows Sustained Efficacy and Safety in Prurigo No... Read Post »
Clinical TrialsPalvella Announces Topline Win for QTORIN in Microcystic Lymphatic Malforma... Palvella Announces Topline Win for QTORIN in Microcystic Lymphatic Malforma... Read Post »
Clinical TrialsArgenx Reports Improved Ocular Symptoms in MG with Subcutaneous VYVGART Argenx Reports Improved Ocular Symptoms in MG with Subcutaneous VYVGART Read Post »
Clinical TrialsEli Lilly’s Orforglipron Outperforms Oral Semaglutide in ACHIEVE‑3 ... Eli Lilly’s Orforglipron Outperforms Oral Semaglutide in ACHIEVE‑3 ... Read Post »
New Drug ApprovalJ&J Seeks FDA Approval of IMAAVY® as First Treatment for wAIHA J&J Seeks FDA Approval of IMAAVY® as First Treatment for wAIHA Read Post »
Clinical TrialsViiV’s Lotivibart Hits 94% HIV Control at 12 Months EMBRACE Data ViiV’s Lotivibart Hits 94% HIV Control at 12 Months EMBRACE Data Read Post »
Clinical TrialsAxsome Therapeutics Doses First Patient in CLARITY Phase 3 Trial Axsome Therapeutics Doses First Patient in CLARITY Phase 3 Trial Read Post »
Clinical TrialsPromising Phase 3 Data for Merck’s Doravirine/Islatravir Combo in HIV Promising Phase 3 Data for Merck’s Doravirine/Islatravir Combo in HIV Read Post »
Drugs Safety AlertFDA Halts New Enrollment in MacroGenics’ Lorigerlimab Trial Over Safe... FDA Halts New Enrollment in MacroGenics’ Lorigerlimab Trial Over Safe... Read Post »
Clinical TrialsBristol Myers Squibb’s Reblozyl Shows Promise in Alpha-Thalassemia: P... Bristol Myers Squibb’s Reblozyl Shows Promise in Alpha-Thalassemia: P... Read Post »
New Drug ApprovalFDA Grants Full Approval to Pfizer’s BRAFTOVI Regimen FDA Grants Full Approval to Pfizer’s BRAFTOVI Regimen Read Post »
